Abstract
Implantation of pacing or defibrillation systems is a serious medical intervention. From this reason, patients have to fulfill certain medical criteria – called indications – before they undergo an implant. Indications are a complex of diagnostic and clinical symptoms presenting within the patient and indicate the suitability of an implantable system according to recent scientific knowledge. According to the indications it is determined which implantable system the patient needs; health insurance companies approve payment for implantation based on the fulfillment of indication criteria.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Insignia AVT/Ultra system guide. Guidant Corporation, St. Paul, © 2003, 283 p
Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC (2009) Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301(8):831–841
Epstein AE et al (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 51(21):e1–e62, May 27
Epstein AE et al (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm 5(6):934–955
Priori SG, Aliot E, Blomstrom-Lundqvist C et al (2003) Update of the guidelines on sudden cardiac death of the European society of cardiology. Eur Heart J 24:13–15
Kautzner J et al (2007) Syncope: diagnosis and treatment. Supplementum Cor Vasa 49(11):63–73
Duska F. Medical publication reading and evaluation. http://www.lf3.cuni.cz/cs/pracoviste/imunologie/vyuka/pvk/. Accessed 14 Nov 2010
Bytesnik J (2002) The efficacy of implantable cardioverter-defibrillators in the prevention of sudden cardiac death: a survey of the current knowledge. Interv Akut Kardiol 1:32–36
Ellenbogen KA, Wood MA et al (2008) Cardiac pacing and ICDs, 5th edn. Blackwell, Malven, 558 p
Ozabalova E (2007) Cardiac resynchronization therapy for patients with chronic heart failure. Ph.D. thesis. Faculty of Medicine, MU Brno, 71 p
Bytesnik J (2004) “Hot information” from the area of primary prevention of sudden death: studies with implantable cardioverters-defibrillators DINAMIT and SCD-HEFT. Interv Akut Kardiol 3:139–141
Krivan L (2005) Primary prevention of sudden cardiac death. Intern Med Prax 1:7–9
Heart Failure (HF): Congestive Heart Failure. Merck manual professional. http://www.merckmanuals.com/professional/cardiovascular_disorders/heart_failure/heart_failure_hf.html. Accessed 11 Jan 2011
Svab P, Simon J (2003) Resynchronization therapy for chronic heart failure – summary of current knowledge. Intern Med Prax 1:14–18
Neuzil P, Taborsky M, Sediva L (2004) Prognostic impact of cardiac resynchronization therapy. Cardiology revue – extra ed: 39–42
Kautzner J (2002) Biventricular pacing: a novel therapeutic option in management of chronic heart failure. Intern Med Prax 6:273–278
Teligen 100 system guide. Boston Scientific, St. Paul. © 2009, 283 p
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Korpas, D. (2013). Indications for Implantable System Treatment. In: Implantable Cardiac Devices Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-6907-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6907-0_6
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-6906-3
Online ISBN: 978-1-4614-6907-0
eBook Packages: MedicineMedicine (R0)